STAT March 20, 2024
WASHINGTON — Medicare will likely choose the obesity drug semaglutide for price negotiation “within the next few years,” according to a new analysis from nonpartisan congressional budget experts. That could curb the cost of legislation requiring Medicare to cover obesity drugs, which would increase the chances of Congress actually passing such a bill.
Right now, Medicare by law cannot cover obesity drugs, though Medicare will pay for seniors to take the same medications for conditions like diabetes and heart problems. Legislation that would do away with the broader coverage restriction hasn’t gained traction, in large part because it would cost the government...
Today's Sponsors
Today's Sponsor